ArticleMicrosystems & nanoengineering2025
3D nanoprinting of embryo microinjection needles with anti-clogging features.
Article in Microsystems & nanoengineering, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Advancing intradermal vaccine delivery: Focus on hollow microneedles and skin models.Human vaccines & immunotherapeutics · 2026Review
- Emerging nanomedicine for liver diseases treatment.Journal of nanobiotechnology · 2025Review
- Pump-Free Insulin Delivery via an SLA-Printed Hollow Microneedle Patch with an Integrated Self-Sealing Reservoir.Micromachines · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
Wide-ranging biomedical applications spanning both research and clinical settings rely on microinjection protocols that involve using a long, hollow microneedle to deliver foreign substances directly into biological targets, such as embryos. Unfortunately, conventional microneedles are prone to clogging-e.g., cytoplasmic material from an embryo becoming lodged inside the needle tip during penetration, thereby obstructing delivery-motivating researchers to use top-down microfabrication techniques to modify needle tips and reduce such failure modes. Recent advancements for the submicron-scale additive manufacturing approach, "Two-Photon Direct Laser Writing (DLW)", offer a new, bottom-up pathway for re-architecting microneedle tips to address clogging susceptibility via geometric means. Here, we investigate this potential by 3D printing monolithic 650-µm-tall, 15-µm-diameter hollow microneedles comprising architectural features designed to remediate clogging phenomena: (i) a solid, fine-point tip, (ii) multiple side ports (i.e., perpendicular to the insertion direction), and (iii) an internal microfilter. Serial microinjection experiments with live zebrafish embryos reveal that the 3D microneedles yield enhanced delivery performance without any instances of complete blockages that are pervasive among both standard glass and 3D-printed control microneedles. These findings suggest that DLW-based 3D printing holds distinctive promise for high-precision microinjection applications, particularly in scenarios involving extensive serial injections or critical payloads and targets.
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.